Bridger Gary
SEC-identified person · CIK 1600049 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| X4 Pharmaceuticals, Inc XFOR | Director | filed 2019–2026 |
| Neurogene Inc. NLTX | Director | filed 2014–2018 |
| Alder Biopharmaceuticals INC ALDR | Director | filed 2014–2015 |
| Xenon Pharmaceuticals Inc. XENE | EVP, Research & Development | filed 2014–2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.